Company profile · Producent (overig)
SomantiX BV
- Biotechnology
- Producent (overig)
- Utrecht
- Biotechnology · Utrecht
- Employees
- 2–10
- Province
- Utrecht
- Country
- Netherlands
About SomantiX BV
SomantiX B.V. is a Dutch biotech company focusing on the identification and development of new angiogenesis inhibitors for the treatment of solid cancers through targeting of tumor blood vessels. Somantix’ screening platform in combination with the binder generation technologies allows validation of new therapeutic targets and development of new cancer medicines.
Team by function
Based on 1 public job profiles as of 4 August 2026.
- Research / R&D1
Similar companies
Companies with a similar profile, Utrecht first.
Keystonemab
Biotechnology · Utrecht
11–50 employeesView profile
Merus N.V.
Biotechnology · Utrecht
201–500 employeesView profile
Sapreme Therapeutics BV
Biotechnology · Utrecht
11–50 employeesView profile
Oncolines B.V.
Biotechnology · Oss
11–50 employeesView profile
VitroScan
Biotechnology · Leiden
2–10 employeesView profile
Looking for more companies like these?
Get a free selection by email, put together by our team.